Wright Lab post doctoral fellow, Dr Manoj Jangra and his team, have discovered a promising new class of antibiotics, called lariocidin, offering hope in the global fight against antimicrobial resistance. Led by Dr. Gerry Wright, the team identified this potent lasso peptide—produced by soil bacteria from a Hamilton backyard—that attacks drug-resistant bacteria in a completely novel way. Published in Nature, the study highlights lariocidin’s unique mechanism, effectiveness in preclinical models, and low toxicity to human cells. This breakthrough marks a major step forward, but the team notes that the road to clinical use requires further optimization and large-scale production. Follow the link to read more about the story and watch the behind the scenes video of how it all went down!